What does CUSIP 04280A100 represent in this 13F holders report?

CUSIP 04280A100 is the security identifier for ARWR - ARROWHEAD PHARMACEUTICALS, INC. - COMMON STOCK used to aggregate holder disclosures.

How many institutions held ARWR - ARROWHEAD PHARMACEUTICALS, INC. - COMMON STOCK in Q2 2019?

207 institutional investors reported ARWR - ARROWHEAD PHARMACEUTICALS, INC. - COMMON STOCK for Q2 2019. Use the holders table for investor-level position and value details.

ARROWHEAD PHARMACEUTICALS, INC. - COMMON STOCK (ARWR)

CUSIP: 04280A100

Q2 2019 13F Holders as of 30 Jun 2019

Type / Class: Equity / COMMON STOCK
Shares outstanding: 141,328,976
Total 13F shares: 68,226,591
Share change: +17,446,256
Total reported value: $1,809,138,980
Put/Call ratio: 75%
Price per share: $26.50
Number of holders: 207
Value change: +$469,493,968
Number of buys: 136
Number of sells: 71

Quarterly Holders Quick Answers

What is CUSIP 04280A100?
CUSIP 04280A100 identifies ARWR - ARROWHEAD PHARMACEUTICALS, INC. - COMMON STOCK in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2019
Previous quarter: Q1 2019

Recent filing periods for CUSIP 04280A100:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of ARWR - ARROWHEAD PHARMACEUTICALS, INC. - COMMON STOCK (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
OppenheimerFunds, Inc.	13F	Company	5.5%	7,803,131	$143,187,000	—	31 Mar 2019	13F
BlackRock Finance, Inc.	13F	Company	5.4%	7,631,074	$140,030,000	—	31 Mar 2019	13F
VANGUARD GROUP INC	13F	Company	3.5%	4,925,446	$90,382,000	—	31 Mar 2019	13F
FIRST MANHATTAN CO. LLC.	13F	Company	3.5%	4,923,525	$90,346,000	—	31 Mar 2019	13F
STATE STREET CORP	13F	Company	3.3%	4,704,597	$86,329,000	—	31 Mar 2019	13F
Vivo Capital, LLC	13F	Company	1.6%	2,328,475	$42,728,000	—	31 Mar 2019	13F
FARALLON CAPITAL MANAGEMENT LLC	13F	Company	1.4%	1,920,609	$35,243,000	—	31 Mar 2019	13F
FMR LLC	13F	Company	1.2%	1,712,539	$31,425,000	—	31 Mar 2019	13F
Fiera Capital Corp	13F	Company	1.1%	1,555,255	$28,538,000	—	31 Mar 2019	13F
RTW INVESTMENTS, LP	13F	Company	1.1%	1,528,213	$28,043,000	—	31 Mar 2019	13F
ADAGE CAPITAL PARTNERS GP, L.L.C.	13F	Company	0.97%	1,375,000	$25,231,000	—	31 Mar 2019	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.88%	1,248,091	$22,902,000	—	31 Mar 2019	13F
NORTHERN TRUST CORP	13F	Company	0.85%	1,196,067	$21,948,000	—	31 Mar 2019	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.82%	1,162,703	$21,335,000	—	31 Mar 2019	13F
Aquilo Capital Management, LLC	13F	Company	0.7%	982,455	$18,028,000	—	31 Mar 2019	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.67%	943,835	$17,319,000	—	31 Mar 2019	13F
Invesco Ltd.	13F	Company	0.52%	741,084	$13,599,000	—	31 Mar 2019	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.44%	622,924	$11,431,000	—	31 Mar 2019	13F
S.c.a. Candriam	13F	Individual	0.42%	594,000	$10,900,000	—	31 Mar 2019	13F
D. E. Shaw & Co., Inc.	13F	Company	0.38%	539,158	$9,893,000	—	31 Mar 2019	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.36%	513,634	$9,424,000	—	31 Mar 2019	13F
Uniplan Investment Counsel, Inc.	13F	Company	0.27%	375,754	$6,895,000	—	31 Mar 2019	13F
Bank of New York Mellon Corp	13F	Company	0.26%	374,264	$6,868,000	—	31 Mar 2019	13F
NEW YORK STATE COMMON RETIREMENT FUND	13F	Company	0.26%	371,657	$6,820,000	—	31 Mar 2019	13F
CWM, LLC	13F	Company	0.06%	82,196	$6,807,000	—	31 Mar 2019	13F
OAK RIDGE INVESTMENTS LLC	13F	Company	0.24%	332,868	$6,108,000	—	31 Mar 2019	13F
PERCEPTIVE ADVISORS LLC	13F	Company	0.23%	330,738	$6,069,000	—	31 Mar 2019	13F
JPMORGAN CHASE & CO	13F	Company	0.21%	303,245	$5,564,000	—	31 Mar 2019	13F
CREDIT SUISSE AG/	13F	Company	0.21%	299,265	$5,492,000	—	31 Mar 2019	13F
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM	13F	Company	0.19%	267,310	$4,905,000	—	31 Mar 2019	13F
MORGAN STANLEY	13F	Company	0.19%	266,817	$4,896,000	—	31 Mar 2019	13F
WELLS FARGO & COMPANY/MN	13F	Company	0.18%	257,287	$4,721,000	—	31 Mar 2019	13F
TEACHERS ADVISORS, LLC	13F	Company	0.16%	221,937	$4,073,000	—	31 Mar 2019	13F
DEUTSCHE BANK AG\	13F	Company	0.15%	216,468	$3,971,000	—	31 Mar 2019	13F
Matarin Capital Management, LLC	13F	Company	0.15%	216,409	$3,971,000	—	31 Mar 2019	13F
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP	13F	Company	0.15%	215,536	$3,955,000	—	31 Mar 2019	13F
Allianz Asset Management GmbH	13F	Company	0.15%	209,745	$3,849,000	—	31 Mar 2019	13F
Rafferty Asset Management, LLC	13F	Company	0.14%	204,150	$3,746,000	—	31 Mar 2019	13F
AQR CAPITAL MANAGEMENT LLC	13F	Company	0.14%	193,951	$3,559,000	—	31 Mar 2019	13F
ClariVest Asset Management LLC	13F	Company	0.12%	172,723	$3,170,000	—	31 Mar 2019	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.12%	170,400	$3,127,000	—	31 Mar 2019	13F
TIAA CREF INVESTMENT MANAGEMENT LLC	13F	Company	0.12%	169,316	$3,107,000	—	31 Mar 2019	13F
ACUTA CAPITAL PARTNERS, LLC	13F	Company	0.12%	167,500	$3,074,000	—	31 Mar 2019	13F
BAMCO INC /NY/	13F	Company	0.12%	167,494	$3,074,000	—	31 Mar 2019	13F
BAILARD, INC.	13F	Company	0.12%	165,600	$3,039,000	—	31 Mar 2019	13F
361 CAPITAL LLC	13F	Company	0.11%	161,839	$2,970,000	—	31 Mar 2019	13F
CITIGROUP INC	13F	Company	0.11%	149,238	$2,738,000	—	31 Mar 2019	13F
Swiss National Bank	13F	Company	0.1%	144,400	$2,650,000	—	31 Mar 2019	13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM	13F	Company	0.1%	143,362	$2,631,000	—	31 Mar 2019	13F
RHUMBLINE ADVISERS	13F	Company	0.09%	124,276	$2,280,000	—	31 Mar 2019	13F

Institutional Holders of ARROWHEAD PHARMACEUTICALS, INC. - COMMON STOCK (ARWR) as of Q2 2019

As of 30 Jun 2019, ARROWHEAD PHARMACEUTICALS, INC. - COMMON STOCK (ARWR) was held by 207 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 68,226,591 shares. The largest 10 holders included BlackRock Inc., VANGUARD GROUP INC, Invesco Ltd., STATE STREET CORP, FIRST MANHATTAN CO, Vivo Capital, LLC, FARALLON CAPITAL MANAGEMENT LLC, Fiera Capital Corp, FMR LLC, and GEODE CAPITAL MANAGEMENT, LLC. This page lists 207 institutional shareholders reporting positions in this security for the Q2 2019 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2019 vs Q1 2019 Across Filers

Q1 2019 holders

172

Q2 2019 holders

207

Holder diff

Investor	Q1 2019 Shares	Q2 2019 Shares	Share Diff	Share Chg %	Q1 2019 Value $	Q2 2019 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.